RBC Capital analyst Nik Modi keeps an Outperform rating and $42 price target on Keurig Dr Pepper ahead of its Q1 results saying the company should clear consensus expectations. The story for the stock "remains the same", the analyst tells investors in a research note, citing packaged beverages seeing steady growth while coffee continues to be pressured as it undergoes normalization.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KDP:
- KDP Upcoming Earnings Report: What to Expect?
- Keurig Dr Pepper call volume above normal and directionally bullish
- Keurig Dr Pepper price target raised to $41 from $40 at JPMorgan
- Keurig Dr Pepper price target raised to $42 from $40 at Barclays
- Keurig Dr Pepper price target lowered to $36 from $38 at Deutsche Bank
